A case series of serious and unexpected adverse drug reactions under treatment with cariprazine

Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.

Detalles Bibliográficos
Autores principales: Heck, Johannes, Seifert, Johanna, Stichtenoth, Dirk O., Schroeder, Christoph, Groh, Adrian, Szycik, Gregor R., Degner, Detlef, Adamovic, Ivana, Schneider, Michael, Glocker, Catherine, Rüther, Eckart, Bleich, Stefan, Grohmann, Renate, Toto, Sermin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142394/
https://www.ncbi.nlm.nih.gov/pubmed/34084502
http://dx.doi.org/10.1002/ccr3.4084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142394/
https://www.ncbi.nlm.nih.gov/pubmed/34084502
http://dx.doi.org/10.1002/ccr3.4084

Ejemplares similares